Paper Details

  1. Home
  2. Paper Details

Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy.

Author: BodeiLisa, KiddMark, Kolasinska-ĆwikłaAgnieszka, ModlinIrvin M, SankowskiArtur, ĆwikłaJarosław B

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Evaluation StudyResearch that systematically evaluates the effectiveness of a particular program or policy. It measures its outcomes and provides important information for future decision-making.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This prospective cohort study investigates the potential of circulating neuroendocrine tumor transcripts (NETest) to predict responses to somatostatin analogs (SSAs) in neuroendocrine neoplasm/tumor management.
Paper Details　
Original Abstract of the Article :
Early and precise delineation of therapeutic responses are key issues in neuroendocrine neoplasm/tumor management. Imaging is currently used but exhibits limitations in sensitivity and specificity. The utility of biomarkers is unclear. objective, setting, and design: This prospective cohort study (1...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1210/jc.2015-2792

データ提供：米国国立医学図書館（NLM）

NETest: A New Tool for Navigating Neuroendocrine Tumors

Neuroendocrine tumors (NETs), a group of cancers that arise from neuroendocrine cells, pose a significant challenge to healthcare providers. This study explores the use of circulating neuroendocrine tumor transcripts (NETest) as a potential diagnostic and prognostic tool for NETs, particularly in patients treated with somatostatin analogs (SSAs). The researchers, like skilled navigators charting an unknown territory, sought to illuminate the potential of NETest in guiding therapy for NET patients.

A New Compass for NET Treatment

The study found that NETest measurements could predict responses to SSAs, providing valuable information to guide treatment decisions. This is like a caravan using a new compass to navigate the desert, allowing them to chart a more efficient and effective course. The authors, like cartographers mapping a new landscape, demonstrated the potential of NETest to improve the precision and effectiveness of NET treatment, offering a new way to track the progress of these challenging tumors.

Precision Medicine: A New Era in NET Treatment

The findings of this study highlight the potential of NETest to usher in a new era of personalized medicine for NET patients, allowing for more targeted and individualized treatment approaches. This is like a desert oasis, where the water sources and resources vary, requiring a tailored approach to ensure survival and well-being. NETest could empower physicians to make more informed decisions, tailoring treatment strategies to meet the unique needs of each patient.

Dr.Camel's Conclusion

This study offers a promising glimpse into the future of NET management, with NETest as a potential game-changer in the diagnostic and prognostic landscape. This tool, like a new and innovative compass, has the potential to guide physicians and patients through the complexities of NET treatment, leading to more personalized and effective care.

Date :
  1. Date Completed 2016-02-25
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

26348352

DOI: Digital Object Identifier

10.1210/jc.2015-2792

Related Literature

Article Analysis
・Effects of pasireotide injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.